Picture of Insight Molecular Diagnostics logo

IMDX — Insight Molecular Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Oncocyte Posts Q3 Loss Per Share Of $0.15

Nov 9 (Reuters) - OncoCyte Corp  OCX.O :
    * ONCOCYTE REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.15
    * Q3 REVENUE $1.0 MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.12, REVENUE VIEW $1.8
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX13c9RR 
Further company coverage:  OCX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Insight Molecular Diagnostics

See all news